June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Subretinal expression of Galectin-3 after light-induced retinal damage
Author Affiliations & Notes
  • Debresha Shelton
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Jana T Sellers
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Micah Chrenek
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Tatiana Getz
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Vivian Summers
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Preston E. Girardot
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Shweta Modgil
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Jeffrey H Boatright
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • John M Nickerson
    Department of Ophthamology, Emory University, Atlanta, Georgia, United States
  • Footnotes
    Commercial Relationships   Debresha Shelton None; Jana Sellers None; Micah Chrenek None; Tatiana Getz None; Vivian Summers None; Preston Girardot None; Shweta Modgil None; Jeffrey Boatright None; John Nickerson None
  • Footnotes
    Support  NIH R01EY028450, R01EY021592, P30EY006360, R01EY028859, T32GM008490-28, T32EY007092, the Abraham and Phyllis Katz Foundation, VA RR&D I01RX002806 and I21RX001924, VA RR&D C9246C (Atlanta Veterans Administration Center for Excellence in Vision and Neurocognitive Rehabilitation), and an unrestricted grant to the Department of Ophthalmology at Emory University from Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3901 – A0103. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Debresha Shelton, Jana T Sellers, Micah Chrenek, Tatiana Getz, Vivian Summers, Preston E. Girardot, Shweta Modgil, Jeffrey H Boatright, John M Nickerson; Subretinal expression of Galectin-3 after light-induced retinal damage. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3901 – A0103.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Galectin-3 (Gal-3), is a β-galactoside-binding protein is purported to be a prognostic biomarker in patients with severe disease (e.g., heart failure or depression). We hypothesized that manipulation of the Vitamin A cycle during light-induced retinal damage (LIRD) could reveal whether increased Gal-3 expression is a predictor of microglia/macrophage deposition within the RPE during damage resolution.

Methods : High activity Rpe65 (L450 (L/L)) and the low activity variant (M450 (M/M)) were bred to Cx3CR1-GFP-mice on C57Bl/6J background. Light damage was conducted at 50,000 lux for 5 h during the dark phase of the circadian cycle. Mice were imaged and sacrificed at days 1, 3, & 7 after damage (age= P60-P365, n=3-4/group). Retinal thickness and morphology were measured via SD-OCT, cSLO, and histopathology. Tissue was collected for RPE flat mounts. GFP+ (microglia/macrophages) and Gal-3+ cells were counted and classified. ZO-1 spatial patterns were measured with CellProfiler and Imaris.

Results : Differences in damage patterns and kinetics between RPE 65 M/M and RPE65L/L mice were evident in both functional and morphological outcomes. On days 1 & 3 post LIRD, GFP+ cells were not significantly different in number between genotypes. Later, on day 7, more GFP+ cells were observed in the RPE 65 L/L mice compared to RPE65 M/M and no damage controls [BJ1] (p<0.0001). Notably, the RPE65L/L mice lost most of their ERG a-, b-, and c-wave amplitudes within the first 24-72 hours post LIRD induction compared to RPE65M/M mice (p<0.005). This phenotype worsened by day 7 post LIRD induction (p<0.001). Retinal detachments occurred earlier in RPE65L/L animals than in the RPE65M/M mice. Expression of Gal-3 in RPE65M/M mice was comparable to RPE65 L/L during early stages of damage (up to day 3 post LIRD induction); however, at day 7, RPE65M/M mice exhibited low levels of Gal-3 while RPE65L/L animals continued to express high levels of the protein heterogeneously in both RPE cells and CX3CR1-GFP+ cells. The distribution of GFP+ cells was correlated with Gal-3 expression patterns in RPE cells in a time-dependent manner after LIRD induction

Conclusions : Changes in subretinal expression of Gal-3 correlate to CX3CR1-GFP+ cell deposition and correspond to functional and morphological damage. Significance: Galectin inhibitory drugs may therapeutically modulate sub-retinal damage via microglia/macrophage-RPE interactions

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×